One study demonstrated that in renal cell carcinoma, MDM2 is able to interact with NME2 and potentially promote the ubiquitylation of NME2 independently of its protein kinase activity; therefore, NME2 is not able to negatively regulate cell migration [144]. This evidence concerns the gene NME2 and renal cell carcinoma.